Translational Biomedicine

  • ISSN: 2172-0479
  • Journal h-index: 18
  • Journal CiteScore: 5.91
  • Journal Impact Factor: 4.11
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • ResearchBible
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Review Article - (2015) Volume 6, Issue 3

Urological Manifestations of Obstructive Sleep Apnea Syndrome: A Review of Current Literature

Gautam Dagur1 Kelly Warren1 Sedrick Ambroise1 Reese Imhof1 and Sardar A. Khan1,2*

1Department of Physiology and Biophysics, SUNY at Stony Brook, New York 11794, USA

2Department of Urology, SUNY at Stony Brook, New York 11794, USA

*Corresponding Author:
Sardar Ali Khan
Professor of Urology and Physiology
HSC Level 9 Room 040 SUNY at Stony
Brook,Stony Brook, NY 11794-8093,USA
Tel: 1-631-987-0132
Fax: 1-631-444-7620

Received Date: September 17, 2015, Accepted Date: December 01, 2015, Published Date: December 03, 2015

Citation: Dagur G, Warren K, Ambroise S, et al. Urological Manifestations of Obstructive Sleep Apnea Syndrome: A Review of Current Literature. Transl Biomed. 2015, 6:3.doi: 10.21767/2172-0479.100022


Renal; Albuminuria; Frequency; Nocturia; Enuresis; Urgency; Hypogonadism; Incontinence; Sexual dysfunction; Lower urinary tract symptoms; Sleep apnea syndrome; Snoring


Obstructive sleep apnea (OSA); Gastro esophageal reflux disease (GERD); Cerebrospinal Fluid (CSF); End-stage Renal Disease (ESRD); Erectile Dysfunction (ED); Continuous Positive Airway Pressure (CPAP); Female Sexual Dysfunction (FSD); Polycystic Ovary Syndrome (PCOS)

Visit for more related articles at Translational Biomedicine


Sleep apnea syndrome is a common health issue that is frequently found in patients with obesity associated cardiovascular and respiratory disorders. Patients with sleep apnea suffer from hypoxia during sleep, resulting in metabolic dysfunction of various organ specific symptoms. Obstructive sleep apnea syndrome results in critical psychological symptoms, which include depression and suicidal tendencies. Sleep apnea syndrome carries significant morbidity and mortality that is frequently ignored by healthcare providers. A high percentage of sleep apnea patients suffer from genitourinary symptoms, such as frequency, nocturia, erectile dysfunction, enuresis, and overactive bladder. Current concepts of sleep apnea, as related to urological health issues, are discussed to facilitate treatment options of sleep apnea syndrome. Current literature is reviewed related to genitourinary symptoms.


Renal; Albuminuria; Frequency; Nocturia; Enuresis; Urgency; Hypogonadism; Incontinence; Sexual dysfunction; Lower urinary tract symptoms; Sleep apnea syndrome; Snoring


Obstructive sleep apnea (OSA); Gastro esophageal reflux disease (GERD); Cerebrospinal Fluid (CSF); End-stage Renal Disease (ESRD); Erectile Dysfunction (ED); Continuous Positive Airway Pressure (CPAP); Female Sexual Dysfunction (FSD); Polycystic Ovary Syndrome (PCOS)


Sleep apnea is defined to be an interruption of breathing during sleep lasting longer than ten seconds, which stimulates the sequence for chronic heart failure. It generates several mechanical, hemodynamic, chemical, and inflammatory changes, which negatively affects cardiovascular equilibrium of patients with heart failure [1]. In obstructive sleep apnea (OSA), respiration ceases when the muscles in the throat relax regardless of respiratory effort [1].


There are many practical pathophysiologic mechanisms that are impaired during the night. There are various components of OSA, including abnormal neuro-hormonal regulation, lack of physical activity, nutritional factors that can be involved in increased dietary sodium intake, and smoking of tobacco; which have all been correlated with blunted circadian rhythm of blood pressure [2]. OSA may increase trans-diaphragmatic pressure and decrease intra-thoracic pressure favoring Gastro esophageal reflux disease (GERD) [3]. Apnea may influence gastric dilation, decrease gastric emptying and influence transient lower esophageal sphincter relaxations [4]. Furthermore, greater respiratory effort increases the pressure gradient across the lower esophageal sphincter and eventually leads to GERD and its consequences.


There are many disturbances that can result in a sleeping disorder, refer to Table 1 [5-11]. Obstructive sleep apnea severity can also be affected by multifactorial and specific symptoms in an individual such as upper airway anatomy, arousal threshold, upper airway muscle drive, and stability of the respiratory control system. Age contributes to the severity, with the likelihood of adults having upper airway collapsibility and younger patients commonly having alterations in ventilator control. Refer to Table 2 [12-19].

Disturbances that lead to sleep disorders
Disturbances References
Alcohol related [5]
Major depressive and bipolar disorder [6]
Psychiatric disorder [7]
Traumatic brain injury [8]
Eating disorders [9]
Neurodegenerative disorders [10]
Bowel disorders [11]

Table 1: Factors resulting in sleeping disorders.

Risk Factors of Obstructive Sleep Apnea Syndrome
Risk Factors References
Cardiovascular [12,13]
Depression [13]
Diabetes Mellitus [13,14]
Obesity [13,14]
Hypertension [15]
Gender [16]
Age [16]
Chronic Kidney Disease [17]
Hypoxemia [18]
Hyperlipidemia [18]
Increased Sympathetic Nerve Activity [18]
Metabolism [19]

Table 2: Risk Factors contributing to obstructive sleep apnea.

Clinical manifestations of obstructive sleep apnea

OSA presents clinical symptoms in a variety of ways. Refer to Table 3 [20-24] for the clinical manifestations.

Clinical Symptoms of Obstructive Sleep Apnea Syndrome
Symptoms References
Snoring [20]
Daytime somnolence [21]
Nasal [22]
Mouth dryness [23]
Nocturia [24]

Table 3: Clinical manifestations of obstructive sleep apnea.

Diagnostic methods of obstructive sleep apnea

Polysomnography is a critical tool used to diagnose patients with OSA. In one study conducted by Fernandez Alonso et al., a questionnaire was used initially to get information from the patients and diagnose patients with OSA. Following the questionnaire, the results were confirmed using polysomnography [25]. Ustun et al. conducted a study to test a new method for diagnosing OSA know as SLIM, Supersparse Linear Integer Models. This technique was compared with 7 other state-ofthe- art classification methods. Results concluded that SLIM is an accountable tool for OSA screening [26].

Clinical manifestations of obstructive sleep apnea

Cardiovascular effects

There are a variety of deleterious processes such as endothelial dysfunction, inflammation, platelet aggregation, and fibrosis, which provoke individuals to adverse cardiovascular events. There is evidence that OSA is significantly associated with cardiovascular disease which uses endothelial dysfunction as a mediating pathway [27].

Cardiopulmonary effects

Frequent arousals derive from upper airway obstruction, which consist of alveolar hypoventilation, altered arterial blood gases and acid-base status, and stimulation of the arterial chemoreceptors. These arousals are the cause of hypersomnolence, which are recurrent episodes of daytime sleepiness. Pulmonary and systemic hypertension can be caused by chronic intermittent alveolar and systemic arterial hypoxia-hypercania which affects the right and left ventricles and the renal system [4]. Noxious stimuli can activate the sympathetic nervous system, depress parasympathetic activity, provoke oxidative stress and systemic inflammation, activate platelets, and impair vascular endothelial function.

Neurological effects

Microvascular complications are associated with sleep apnea [28]. OSA is associated with reduced basal and functional capillary rarefaction with an additional risk of impaired peripheral perfusion. The mechanisms involved in this relation are most likely induced by the periodic hypoxia/reoxygenation that characteristically occur in OSA, which results in oxidative stress, endothelial dysfunction, and activation of the inflammatory cascade. On the other hand, the hypoxemia results in peripheral nerve damage by harming the vasanervorum in the early stages of ischemia, mechanisms to reduce peripheral neuropathy are activated, but these become insufficient over time, and obvious neuropathy is inevitable in chronic hypoxemia [29]. A correlation suggests a link between OSA and glaucoma or nonarteritic anterior ischemic optic neuropathy. This is believed to be secondary to direct hypoxia or optic nerve head vascular dysregulation. Patients with OSA are reported having papilledema and increased intracranial pressure. This is thought to be due to increased cerebral perfusion pressure and cerebral venous dilation, secondary to hypoxia and hypercapnia [30]. There are not any correlations between the autonomic system and the neurobehavioral changes, which led to the belief that they have separate pathophysiological pathways [31]. There is an indirect link, which has been associated with OSA patients with nocturia, which consists of increased sympathetic levels and decreased parasympathetic levels [32]. OSA tends to coexist with autonomic regulatory dysfunction normally in the central region, which can damage the cardiovascular system and cause severe conditions [33]. It is unclear whether OSA is secondary to intracranial hypertension. Fleischman et al. examined the relationship between cerebrospinal fluid (CSF) rhinorrhea and OSA. Results found that patients with spontaneous CSF rhinorrhea were more likely to be diagnosed with OSA. Spontaneous CSF rhinorrhea is known to cause intracranial hypertension, and patients should be screened for spontaneous CSF rhinorrhea relating to OSA [34]. Bakhsheshian et al. reviewed cases of spontaneous CSF leaks, and found a connection with OSA, through increased intracranial pressure. However, further studies need to be conducted to evaluate the relationsc [35].

Metabolic effects

Impaired glucose metabolism is associated with obese patients with OSA [36]. Night hypoxia is correlated with glucose levels, which shows that it has an effect on glucose metabolism with OSA patients [37]. Glucose tolerance impairment and pancreatic betacell function is associated with OSA, but insulin sensitivity is due to obesity [18,38]. Vitamin D deficiency can play a role in glucose metabolism in patients with OSA [39]. OSA is accompanied by increased hormonal levels such as adrenocorticotropic hormone, which leads to alterations in tissue [40]. These alterations eventually end up disturbing the feedback mechanisms to regulate hormonal levels [41]. Studies have shown that Bisphenol A, which disturbs the endocrine system, has an important function in the pathogenesis of OSA [42].

Psychological effects

Depression is the most prevalent psychological effect for patients dealing with OSA. Bjornsdottir et al. sought to determine prevalence of depression among patients with OSA using psychiatric interview. The results of the interview concluded that mild depression was more prevalent among women than men. However, major depression had no significant differences among sexes. Depression and OSA are believed to be dependent on one another in these patients, and assessment tools should test for both to improve diagnostic accuracy [43]. Patients dealing with insomnia are at risk for suicidal ideation, all due to OSA. Choi et al. conducted a study to determine the prevalence of suicidal thoughts among OSA patients, using a questionnaire. The study found the severity of insomnia was positively correlated with depressive mood and suicidal ideation. There was significant association between OSA and suicidal ideation, additional to insomnia [44].

Urological Manifestations of Obstructive Sleep Apnea


There is a high risk for chronic kidney disease that is associated with patients who have severe OSA without hypertension or diabetes [45]. Hypoxemia and sleep fragmentation are correlated with OSA, which leads to activation of the sympathetic nervous system, activation of the renin-angiotensin-aldosterone system, cardiovascular hemodynamics alteration, and causes free radical generation. This can lead to endothelial dysfunction, inflammation, platelet aggregation, atherosclerosis, and fibrosis, which can predispose individuals to cardiovascular events such as renal damage and proteinuria through hemodynamic changes, ischemic stress, and intermediary condition such as hypertension [46]. Renal transplants can heal patients, but there is a prominent probability of the patient developing OSA in the post-operational stage [47]. End-stage renal disease (ESRD) is believed to increase the severity of OSA due to the reduced upper way area and the destabilization of ventilator control, which creates a cycle that causes OSA fluid overload disorders such as congestive heart failure and ESRD [48]. ESRD also contributes to the pathogenesis of OSA and treatment by ultrafiltration reduces the effects of OSA without altering uremic status [49]. ESRD patients seem to show a correlation with leg fluid volume and left atrial size, which is also linked to OSA severity [50]. Renal vasodilation and endothelial dysfunction are characteristics of OSA [51].

Neurogenic bladder

Sporadic hypoxia in OSA patients results in oxidative stress which can lead to alterations in bladder, detrusor instability, and spontaneous contractions through the activation of cell survival signaling from OSA [52]. There is a 95% ratio that patients with bladder pain syndrome/interstitial cystitis also have OSA [53]. Patients with benign prosthetic enlargement who frequently awake from sleep to urinate might possibly have OSA [54]. An increasing manifestation of overactive bladder and urgency incontinence in males is correlated with an increasing severity of OSA [55]. Nocturnal urination is also correlated with OSA severity, excessive daytime sleepiness, and coronary artery disease [56]. Bladder function may be damaged during chronic obstructive sleep apnea hypopnea syndrome [57].


Patients with severe OSA reported nocturnal urination three times more frequently than those with moderate OSA [58].


OSA induces systemic inflammatory processes, which can damage tissue and lead to prostatic enlargement. This can lead to an increased risk of benign prostate hyperplasia development, which is age dependent [59].


Nocturia is a very common and severe disorder because of the effects it has on patients [60]. In OSA patients, nocturia is a strong independent predictor of hypertension [61]. Nocturnal urination is also correlated with OSA severity, excessive daytime sleepiness, and coronary artery disease [56,62]. The analysis of a 24 hour urine collection provides constructive data on the pattern of water and solute excretion, which could aid in determining the underlying mechanism of nocturia and monitor treatment [63]. Hypoxemic children with OSA exhibit enuresis of antidiuretic hormone, which is associated with polyuria and nocturia [64]. Atrial natriuretic peptide increases sodium and water excretion which leads to the inhibition of other regulatory hormonal systems such as fluid volume, vasopressin, and renin-angiotensin-aldosterone complex [65]. Nocturnal enuresis and OSA tend to be common conditions during adolescence, which is accompanied with bedwetting due to OSA severity [66]. Nocturnal enuresis severity increases as severity of OSA increases, especially in female children [67].

Sexual Manifestations of Obstructive Sleep Apnea


OSA in males is recognized as an underlying pathogenic factor to sexual dysfunction [68]. Males with sexual dysfunction tend to have higher systolic blood pressure and TNF-alpha [69]. Sexual dysfunction severity in aging men is due to modifiable risk factors [70]. There are many sexual dysfunctions in men that seem to be linked such as erectile dysfunction (ED), low dyadic, and solitary sexual desire, which share many risk factors. There are other factors that are unique to each and they should be addressed before any other outcome is reached. ED factors include increasing age, depression, body fat mass, and hypertension. Unique factors for solitary sexual desire include absence of partner, lower education, income, unemployment and migration, whereas low dyadic unique factors include lower plasma testosterone [71]. There is a direct relationship between erectile dysfunction, vascular dysfunction, neurobehavioral cognitive function and endothelial dysfunction [72]. Endothelial dysfunction is the pathophysiological mechanism that links OSA to ED. There is strong evidence that suggests OSA independently causes endothelial dysfunction which is linked to ED [73]. Inflammatory cytokines, chemokines, and adhesion molecules induce endothelial dysfunction [74]. Surgical and nonsurgical treatment of OSA is correlated with alleviating sexual dysfunction [75]. ED patients that were treated with continuous positive airway pressure (CPAP) saw positive improvements after three months [76]. Oral appliances can be an alternative method of treatment for erectile dysfunction of OSA induced ED patients [77]. Studies have shown that slidenafil is a better alternative than continuous positive airway pressure (CPAP) for treating ED [78].

Obesity and OSA share many similar sexual manifestations. One in particular is male infertility. Katib et al. reviewed the links between obesity and male infertility. The publications reviewed indicate that impaired spermatogenesis resulted from hypotestosteronaemia defects [79]. Torres et al. [80] and Hirotsu et al. [81], conducted studies in mice mimicking sleep apnea and found intermittent hypoxia could lead to reduced fertility.

Sleep-related painful erection is a rare disorder that is identified with painful nocturnal erection, a correlation between REM sleep and pain, and an absence of pain during sexual activity [82]. Cinitapride is effective at reducing sleep-related painful erection due to the regulation of neurotransmitters involved in erection [83].


OSA is associated with a decrease in pituitary-gonadal function [84]. Clinical presentation varies due to the time of onset of androgen deficiency. Defects can occur from a disorder in testosterone production or spermatogenesis, genetic factors, or androgen therapy. Hypogonadism is determined on the basis of consistent signs and symptoms of androgen deficiency and low morning testosterone levels [85]. It is suggested that in males, sleep rhythm is linked to the androgenic hormonal profile, but not to the chronobiological diurnal rhythm [86]. Low testosterone levels are strongly associated with fatigue in OSA patients [87]. CPAP therapy has reversed the effects of OSA by increasing testosterone in patients with low testosterone, bringing them back to normal levels. It has also improved many other hypogonadism symptoms such as fatigue and depression [88]. Hypoxemia also plays a role in decreased testosterone levels in patients with OSA [89]. Studies have shown that testosterone therapy aggravates OSA symptoms at 6-7 weeks, but not after 18 weeks, which can be due to ventilator chemo reflexes changes [90].


Female sexual dysfunction (FSD) is defined when the sexual cycle is impaired due to stress. In premenopausal women, FSD and OSA are correlated only when nocturnal hypoxia is present [91]. OSA is correlated with sexual dysfunction, but there is no correlation between the severity of OSA and the severity of sexual dysfunction [92]. OSA in females corresponds with premenopausal and postmenopausal women. Progesterone is what connects sexual dysfunction to OSA in premenopausal women [93]. Changes in the prolactin secretion in OSA patients is thought to be correlated with hypoxic stress and subsequently to result in reversible changes with continuous positive airway pressure (CPAP) therapy [94]. OSA can alter circulating placentasecreted glycoproteins and markers of angiogenesis in pregnant women [95]. OSA is associated more with glucose intolerance in premenopausal women than postmenopausal women. Improving lifestyle can improve nocturnal hypoxia, which can allow glucose homeostasis [96]. It has been reported that female patients with OSA have seen improvements in sexual dysfunction after a year of CPAP treatment [97]. Post menopause stages and waist size are correlated with the severity of OSA. Reducing the circumference of the waist can reduce OSA symptoms [98]. Postmenopausal women can be diagnosed with a very common condition called polycystic ovary syndrome (PCOS), which causes high androgen levels, low estrogen levels, and is correlated with OSA [99]. Women with polycystic ovary syndrome (PCOS) tend to develop OSA, which in turn can lead to the development of nonalcoholic fatty liver disease [100]. There are two main types of PCOS, the two types consist of PCOS with OSA and PCOS without OSA [101]. Studies have shown that women with PCOS with OSA are often obese, and that obesity should be looked at as the prime factor for the development of OSA [102]. PCOS is usually accompanied by certain characteristics such as insulin resistance, glucose intolerance, and type 2 diabetes, which can be linked to the onset of OSA [103].


Non-Invasive treatment

Positive airway pressure is an effective method for treating patients with moderate and severe OSA [104]. The gold standard treatment for OSA is nasal continuous positive air pressure, which is correlated with improving sexual functioning and improving quality of life [68]. CPAP is suggested to be capable of reversing the effects of OSA induced sexual dysfunctions [105].

CPAP is associated with improving reduced cerebral glucose metabolism in the precentral gyrus and cingulate cortex [106]. CPAP therapy can decrease the excretion of nocturnal atrial natriuretic peptides and improve motility of the detrusor of the bladder [57]. CPAP therapy can also reduce excretion of urinary albumin [107]. CPAP therapy is effective at decreasing daytime fatigue and sequelae of untreated OSA [108]. Long term CPAP treatment does not have any effects on testosterone or estradiol levels [109]. Adaptive servo-ventilation efficiently decreases sleep apnea. Left ventricular ejection fraction and other aspects of life qualities are improved within six months of treatment [110]. Supplementation treatment exhibited improvement to the glucose metabolism and inflammation [39]. Renal sympathetic denervation is associated with significantly reducing severity in OSA [111]. In mild OSA cases, nonsurgical treatments such as CPAP are first line therapy [112].

Invasive treatment

Upper airway surgery can improve the quality of sleep in patients with OSA [113]. Mandibular advancement is another surgical procedure that seems to be effective in treating OSA [75]. Surgery improves clinical outcomes, systolic blood pressure, lipid profile, and increases the number of endothelial progenitor cells, which are correlated with endothelial impairment [114]. Removal of tonsils and adenoids leads to significant improvements. Adenotonsillectomy is considered to be first line therapy in severe OSA [112]. Multilevel surgery targeting the retropalatal and tongue-base was effective in reducing mean platelet volume and apnea hypopnea index. Mean platelet volume is known to be predictors of cardiovascular diseases, hypertension, and stroke [115]. Surgery is effective at improving overnight polysomnography in obese children [116].


Obstructive sleep apnea (OSA) syndrome carries significant morbidity and mortality, frequently associated with obesity. Urological manifestation of OSA, as related to lower urinary tract symptoms and male and female sexual dysfunction are discussed. Non-invasive and invasive treatment options are outlined.


We gratefully acknowledge literature research assistance from Mrs. Wendy Isser, Ms. Grace Garey, Ms. Amanda Dalpiaz, and Mr. Richard Schwamb.

Compliance with Ethical Standards

The authors declare they have no conflict of interest.



  1. Monda C, Scala O, Paolillo S, Savarese G, Cecere M, et al. (2010) Sleep apnea and heart failure: pathophysiology, diagnosis and therapy.G ItalCardiol (Rome) 11: 815-822.
  2. Kanbay M, Turgut F, Uyar ME, Akcay A, Covic A (2008) Causes and mechanisms of nondipping hypertension.ClinExpHypertens 30: 585-597.
  3. Rizzi CF, Cintra F, Mello-Fujita L, Rios LF, Mendonca ET, et al. (2013) Does obstructive sleep apnea impair the cardiopulmonary response to exercise?Sleep 36: 547-553.
  4. Levitzky MG (2008) Using the pathophysiology of obstructive sleep apnea to teach cardiopulmonary integration.AdvPhysiolEduc 32: 196-202.
  5. Brooks AT, Wallen GR (2014) Sleep Disturbances in Individuals with Alcohol-Related Disorders: A Review of Cognitive-Behavioral Therapy for Insomnia (CBT-I) and Associated Non-Pharmacological Therapies. Subst Abuse 8: 55-62.
  6. Lai YC, Huang MC2, Chen HC3, Lu MK4, Chiu YH5, et al. (2014) Familiality and clinical outcomes of sleep disturbances in major depressive and bipolar disorders.J Psychosom Res 76: 61-67.
  7. Krysiak-Rogala K, Jernajczyk W (2013) Sleep disturbances in children and adolescents with psychiatric disorders - affective and anxiety disorders.Psychiatr Pol 47: 303-312.
  8. Mathias JL, Alvaro PK (2012) Prevalence of sleep disturbances, disorders, and problems following traumatic brain injury: a meta-analysis. Sleep Med 13: 898-905.
  9. Cinosi E, Di Iorio G, Acciavatti T, Cornelio M, Vellante F, et al. (2011) Sleep disturbances in eating disorders: a review.ClinTer 162: e195-202.
  10. Gagnon JF, Petit D, Latreille V, Montplaisir J (2008) Neurobiology of sleep disturbances in neurodegenerative disorders.Curr Pharm Des 14: 3430-3445.
  11. Zhen Lu W, Ann Gwee K, Yu Ho K (2006) Functional bowel disorders in rotating shift nurses may be related to sleep disturbances. Eur J GastroenterolHepatol 18: 623-637.
  12. Oki Y (1999) Multiple cardiovascular risk factors in obstructive sleep apnea syndrome patients and an attempt at lifestyle modification using telemedicine-based education. Psychiatry ClinNeurosci 53: 311-313.
  13. Al-Alawi A, Mulgrew A, Tench E, Ryan CF (2006) Prevalence, risk factors and impact on daytime sleepiness and hypertension of periodic leg movements with arousals in patients with obstructive sleep apnea.J Clin Sleep Med 2: 281-287.
  14. Al Lawati NM, Patel SR, Ayas NT (2009) Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration.ProgCardiovasc Dis 51: 285-293.
  15. Costa C, Santos B, Severino D, Cabanelas N, Peres M, et al. (2015) Obstructive sleep apnea syndrome: An important piece in the puzzle of cardiovascular risk factors.ClinInvestigArterioscler 27: 256-263.
  16. Vozoris NT (2012) Sleep apnea-plus: prevalence, risk factors, and association with cardiovascular diseases using United States population-level data.Sleep Med 13: 637-644.
  17. Agrawal V, Vanhecke TE, Rai B, Franklin BA, Sangal RB, et al. (2009) Albuminuria and renal function in obese adults evaluated for obstructive sleep apnea.Nephron ClinPract 113: c140-147.
  18. Büchner NJ, Henning BF, Hägele KF, Quack IA, Rump LC (2004) [Renal function in hypertensive patients with obstructive sleep apnea].Dtsch Med Wochenschr 129: 305-309.
  19. Liu W, Ge R, Mei X, He T, Zhang Q, et al. (2010) Effect of obstructive sleep apnea- hypopnea syndrome on hypertension and metabolism disorder.Lin Chung Er Bi Yan HouTou Jing WaiKeZaZhi 24: 1074-1076.
  20. Bjorvatn B, Pallesen S, Grønli J, Sivertsen B, Lehmann S (2014) Prevalence and correlates of insomnia and excessive sleepiness in adults with obstructive sleep apnea symptoms.Percept Mot Skills 118: 571-586.
  21. Leclerc G (2014) Do obstructive sleep apnea syndrome patients underestimate their daytime symptoms before continuous positive airway pressure treatment? Can Respir J 21: 216-220.
  22. Lasters F, Mallegho C, Boudewyns A, Vanderveken O, Cox T, et al. (2014) Nasal symptoms in patients with obstructive sleep apnea and their impact on therapeutic compliance with continuous positive airway pressure.ActaClinBelg 69: 87-91.
  23. Kreivi HR, Virkkula P, Lehto JT, Brander PE (2012) Upper airway symptoms in primary snoring and in sleep apnea.ActaOtolaryngol 132: 510-518.
  24. Romero E, Krakow B, Haynes P, Ulibarri V (2010) Nocturia and snoring: predictive symptoms for obstructive sleep apnea.Sleep Breath 14: 337-343.
  25. Fernandez Alonso AMP Chedraui, Perez-Lopez FR (2015) Assessment of obstructive sleep apnea-hypopnea syndrome risk at the end of pregnancy using the Berlin Questionnaire. GynecolEndocrinol 1-5.
  26. Ustun B, Westover MB, Rudin C, Bianchi MT (2015) Clinical Prediction Models for Sleep Apnea: The Importance of Medical History over Symptoms.J Clin Sleep Med .
  27. Faulx MD, Storfer-Isser A, Kirchner HL, Jenny NS, Tracy RP, et al. (2007) Obstructive sleep apnea is associated with increased urinary albumin excretion.Sleep 30: 923-929.
  28. Kosseifi S (2010) The association between obstructive sleep apnea syndrome and microvascular complications in well-controlled diabetic patients. Mil Med 175: 913-916.
  29. Casale M, Vesperini E, Potena M, Pappacena M, Bressi F, et al. (2012) Is obstructive sleep apnea syndrome a risk factor for auditory pathway?Sleep Breath 16: 413-417.
  30. Fraser CL (2014) Obstructive sleep apnea and optic neuropathy: is there a link?CurrNeurolNeurosci Rep 14: 465.
  31. Idiaquez J, Santos I, Santin J, Del Rio R, Iturriaga R (2014) Neurobehavioral and autonomic alterations in adults with obstructive sleep apnea.Sleep Med 15: 1319-1323.
  32. Chaidas K, Tsaoussoglou M, Theodorou E, Lianou L, Chrousos G, et al. (2014) Poincaré plot width, morning urine norepinephrine levels, and autonomic imbalance in children with obstructive sleep apnea.PediatrNeurol 51: 246-251.
  33. Macey PM, Kumar R, Woo MA, Yan-Go FL, Harper RM (2013) Heart rate responses to autonomic challenges in obstructive sleep apnea.PLoS One 8: e76631.
  34. Fleischman GM (2014) Obstructive sleep apnea in patients undergoing endoscopic surgical repair of cerebrospinal fluid rhinorrhea. Laryngoscope 124: 2645-2650.
  35. Bakhsheshian JMS Hwang, Friedman M (2015) Association Between Obstructive Sleep Apnea and Spontaneous Cerebrospinal Fluid Leaks: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg 141: 733-738.
  36. Cizza G, Piaggi P, Lucassen EA, de Jonge L, Walter M, et al. (2013) Obstructive sleep apnea is a predictor of abnormal glucose metabolism in chronically sleep deprived obese adults.PLoS One 8: e65400.
  37. Sökücü SN, Karasulu L, Dalar L, Ozdemir C, Seyhan EC, et al. (2013) Effect of hypoxia on glucose metabolism in nondiabetic patients with obstructive sleep apnea syndrome.Arch Bronconeumol 49: 321-325.
  38. Gu CJ, Li M, Li QY, Li N, Shi GC, et al. (2013) Obstructive sleep apnea is associated with impaired glucose metabolism in Han Chinese subjects.Chin Med J (Engl) 126: 5-10.
  39. Bozkurt NC, Cakal E, Sahin M, Ozkaya EC, Firat H, et al. (2012) The relation of serum 25-hydroxyvitamin-D levels with severity of obstructive sleep apnea and glucose metabolism abnormalities.Endocrine 41: 518-525.
  40. Henley DE, Russell GM, Douthwaite JA, Wood SA, Buchanan F, et al. (2009) Hypothalamic-pituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy.J ClinEndocrinolMetab 94: 4234-4242.
  41. Feng XW (2006) Regulation of hypothalamus-pituitary-adrenal axis and growth hormone axis in obstructive sleep apnea-hypopnea syndrome patients. ZhonghuaJie He He Hu Xi ZaZhi 29: 230-232.
  42. Erden ES, Genc S, Motor S, Ustun I, Ulutas KT, et al. (2014) Investigation of serum bisphenol A, vitamin D, and parathyroid hormone levels in patients with obstructive sleep apnea syndrome.Endocrine 45: 311-318.
  43. Bjornsdottir E (2015) The Prevalence of Depression among Untreated Obstructive Sleep Apnea Patients Using a Standardized Psychiatric Interview. J Clin Sleep Med.
  44. Choi SJ, Joo EY2, Lee YJ3, Hong SB4 (2015) Suicidal ideation and insomnia symptoms in subjects with obstructive sleep apnea syndrome.Sleep Med 16: 1146-1150.
  45. Chou YT (2011) Obstructive sleep apnea: a stand-alone risk factor for chronic kidney disease. Nephrol Dial Transplant 26: 2244-2250.
  46. Adeseun GA, Rosas SE (2010) The impact of obstructive sleep apnea on chronic kidney disease.CurrHypertens Rep 12: 378-383.
  47. Sim JJ, Rasgon SA, Derose SF (2010) Review article: Managing sleep apnoea in kidney diseases.Nephrology (Carlton) 15: 146-152.
  48. Roumelioti ME, Brown LK, Unruh ML (2015) The Relationship Between Volume Overload in End-Stage Renal Disease and Obstructive Sleep Apnea.Semin Dial 28: 508-513.
  49. Lyons OD, Chan CT, Yadollahi A, Bradley TD (2015) Effect of ultrafiltration on sleep apnea and sleep structure in patients with end-stage renal disease.Am J RespirCrit Care Med 191: 1287-1294.
  50. Lyons OD, Chan CT, Elias RM, Bradley TD (2014) Relationship of left atrial size to obstructive sleep apnea severity in end-stage renal disease.Sleep Med 15: 1314-1318.
  51. Bruno RM (2013) Renalvasodilating capacity and endothelial function are impaired in patients with obstructive sleep apnea syndrome and no traditional cardiovascular risk factors. J Hypertens 31: 1456-1464.
  52. Witthaus MW, Nipa F, Yang JH, Li Y, Lerner LB, et al. (2015) Bladder oxidative stress in sleep apnea contributes to detrusor instability and nocturia.J Urol 193: 1692-1699.
  53. Chung SD, Lin CC, Liu SP, Lin HC (2014) Obstructive sleep apnea increases the risk of bladder pain syndrome/interstitial cystitis: a population-based matched-cohort study.NeurourolUrodyn 33: 278-282.
  54. Tandeter H, Gendler S, Dreiher J, Tarasiuk A (2011) Nocturic episodes in patients with benign prostatic enlargement may suggest the presence of obstructive sleep apnea.J Am Board Fam Med 24: 146-151.
  55. Kemmer H, Mathes AM, Dilk O, Gröschel A, Grass C, et al. (2009) Obstructive sleep apnea syndrome is associated with overactive bladder and urgency incontinence in men.Sleep 32: 271-275.
  56. Pływaczewski R, Stokłosa A, Bednarek M, Czerniawska J, Bieleń P, et al. (2007) [Nocturia in obstructive sleep apnoea (OSA)].PneumonolAlergol Pol 75: 140-146.
  57. Hu K, Tu ZS, Lü SQ, Li QQ, Chen XQ (2011) Urodynamic changes in patients with obstructive sleep apnea-hypopnea syndrome and nocturnal polyuria.ZhonghuaJie He He Hu Xi ZaZhi 34: 182-186.
  58. Kaynak H, Kaynak D, Oztura I (2004) Does frequency of nocturnal urination reflect the severity of sleep-disordered breathing?J Sleep Res 13: 173-176.
  59. Chou PS, Chang WC, Chou WP, Liu ME, Lai CL, et al. (2014) Increased risk of benign prostate hyperplasia in sleep apnea patients: a nationwide population-based study.PLoS One 9: e93081.
  60. Ayik S, Bal K, Akhan G (2014) The association of nocturia with sleep disorders and metabolic and chronic pulmonary conditions: data derived from the polysomnographic evaluations of 730 patients.Turk J Med Sci 44: 249-254.
  61. Destors M, Tamisier R, Sapene M, Grillet Y, Baguet JP, et al. (2015) Nocturia is an independent predictive factor of prevalent hypertension in obstructive sleep apnea patients.Sleep Med 16: 652-658.
  62. Peyronnet B, Pradère B, Bruyère F (2014) Management of nocturia: a nosological entity within lower urinary tract symptoms in men.ProgUrol 24: 80-86.
  63. Waters P, Hack MA, Richards J, Penney MD (2011) Quantitating nocturia: a study into the recording of solute and water excretion to determine causation.Ann ClinBiochem 48: 321-326.
  64. Yue Z, Wang M, Xu W, Li H, Wang H (2009) Secretion of antidiuretic hormone in children with obstructive sleep apnea-hypopnea syndrome.ActaOtolaryngol 129: 867-871.
  65. Umlauf MG, Chasens ER (2003) Sleep disordered breathing and nocturnal polyuria: nocturia and enuresis.Sleep Med Rev 7: 403-411.
  66. El-Mitwalli A, Bediwy AS, Zaher AA, Belal T, Saleh AB (2014) Sleep apnea in children with refractory monosymptomatic nocturnal enuresis.Nat Sci Sleep 6: 37-42.
  67. Alexopoulos E, Malakasioti G, Varlami V, Miligkos M, Gourgoulianis K, et al. (2014) Nocturnal enuresis is associated with moderate-to-severe obstructive sleep apnea in children with snoring.Pediatr Res 76: 555-559.
  68. Khafagy AH, Khafagy AH (2012) Treatment of obstructive sleep apnoea as a therapeutic modality for associated erectile dysfunction.Int J ClinPract 66: 1204-1208.
  69. Matos G, Hirotsu C, Alvarenga TA, Cintra F, Bittencourt L, et al. (2013) The association between TNF-α and erectile dysfunction complaints.Andrology 1: 872-878.
  70. Martin SA, Atlantis E, Lange K, Taylor AW, O'Loughlin P, et al. (2014) Predictors of sexual dysfunction incidence and remission in men.J Sex Med 11: 1136-1147.
  71. Martin S, Atlantis E, Wilson D, Lange K, Haren MT, et al. (2012) Clinical and biopsychosocial determinants of sexual dysfunction in middle-aged and older Australian men.J Sex Med 9: 2093-2103.
  72. Popp R, Kleemann Y, Burger M, Pfeifer M, Arzt M, et al. (2015) Impaired vigilance is associated with erectile dysfunction in patients with sleep apnea.J Sex Med 12: 405-415.
  73. Hoyos CM, Melehan KL, Phillips CL, Grunstein RR, Liu PY (2015) To ED or not to ED--is erectile dysfunction in obstructive sleep apnea related to endothelial dysfunction?Sleep Med Rev 20: 5-14.
  74. Bouloukaki I, Papadimitriou V, Sofras F, Mermigkis C, Moniaki V, et al. (2014) Abnormal cytokine profile in patients with obstructive sleep apnea-hypopnea syndrome and erectile dysfunction.Mediators Inflamm 2014: 568951.
  75. Shin HW, Park JH, Park JW, Rhee CS, Lee CH, et al. (2013) Effects of surgical vs. nonsurgical therapy on erectile dysfunction and quality of life in obstructive sleep apnea syndrome: a pilot study.J Sex Med 10: 2053-2059.
  76. Husnu T, Ersoz A, Bulent E, Tacettin O, Remzi A, et al. (2015) Obstructive sleep apnea syndrome and erectile dysfunction: does long term continuous positive airway pressure therapy improve erections?Afr Health Sci 15: 171-179.
  77. Zhang T, Li J, Yang P (2014) Oral-appliance for erectile dysfunction induced by obstructive sleep apnea-hypopnea syndrome.Zhonghua Nan KeXue 20: 510-513.
  78. Li X, Dong Z, Wan Y, Wang Z (2010) Sildenafil versus continuous positive airway pressure for erectile dysfunction in men with obstructive sleep apnea: a meta-analysis.Aging Male 13: 82-86.
  79. Katib A (2015) Mechanisms linking obesity to male infertility.Cent European J Urol 68: 79-85.
  80. Torres M, Laguna-Barraza R, Dalmases M, Calle A, Pericuesta E, et al. (2014) Male fertility is reduced by chronic intermittent hypoxia mimicking sleep apnea in mice.Sleep 37: 1757-1765.
  81. Hirotsu C, Tufik S, Levy Andersen M (2014) Sleep apnea as a potential threat to reproduction.Sleep 37: 1731-1732.
  82. Ferré A, Vila J, Jurado MJ, Arcalis N, Camps J, et al. (2012) Sleep-related painful erections associated with obstructive sleep apnea syndrome.Arch Sex Behav 41: 1059-1063.
  83. Chiner E, Sancho-Chust JN, Llombart M, Camarasa A, Senent C, et al. (2010) Sleep-related painful erection in a 50-year-old man successfully treated with cinitapride.J Sex Med 7: 3789-3792.
  84. Luboshitzky R, Lavie L, Shen-Orr Z, Herer P (2005) Altered luteinizing hormone and testosterone secretion in middle-aged obese men with obstructive sleep apnea.Obes Res 13: 780-786.
  85. Holka-Pokorska J, Jarema M, Wichniak A (2014) Androgens - a common biological marker of sleep disorders and selected sexual dysfunctions?.Psychiatr Pol 48: 701-714.
  86. Bercea RM, Mihaescu T1,, Cojocaru C, et al. (2015) Fatigue and serum testosterone in obstructive sleep apnea patients.ClinRespir J 9: 342-349.
  87. Bercea RBB, Mihaescu T (2012) Association between the serum level of testosterone and other comorbidities in obstructive sleep apnea. Pneumologia 61: 98-101.
  88. Molina FD, Suman M, Carvalho TB, Piatto VB, Taboga SR, et al. (2011) Evaluation of testosterone serum levels in patients with obstructive sleep apnea syndrome.Braz J Otorhinolaryngol 77: 88-95.
  89. Killick R, Wang D, Hoyos CM, Yee BJ, Grunstein RR, et al. (2013) The effects of testosterone on ventilatory responses in men with obstructive sleep apnea: a randomised, placebo-controlled trial.J Sleep Res 22: 331-336.
  90. Fanfulla F, Camera A, Fulgoni P, Chiovato L, Nappi RE (2013) Sexual dysfunction in obese women: does obstructive sleep apnea play a role?Sleep Med 14: 252-256.
  91. Onem K, Erol B, Sanli O, Kadioglu P, Yalin AS, et al. (2008) Is sexual dysfunction in women with obstructive sleep apnea-hypopnea syndrome associated with the severity of the disease? A pilot study.J Sex Med 5: 2600-2609.
  92. Stavaras C, Pastaka C, Papala M, Gravas S, Tzortzis V, et al. (2012) Sexual function in pre- and post-menopausal women with obstructive sleep apnea syndrome.Int J Impot Res 24: 228-233.
  93. Macrea MM, Martin TJ, Zagrean L (2010) Infertility and obstructive sleep apnea: the effect of continuous positive airway pressure therapy on serum prolactin levels. Sleep Breath 14: 253-257.
  94. Bourjeily G, Curran P, Butterfield K, Maredia H, Carpenter M, et al. (2015) Placenta-secreted circulating markers in pregnant women with obstructive sleep apnea.J Perinat Med 43: 81-87.
  95. Gilardini L, Lombardi C, Redaelli G, Vallone L, Faini A, et al. (2013) Glucose tolerance and weight loss in obese women with obstructive sleep apnea.PLoS One 8: e61382.
  96. Petersen M, Kristensen E, Berg S, Midgren B (2013) Long-term effects of continuous positive airway pressure treatment on sexuality in female patients with obstructive sleep apnea.Sex Med 1: 62-68.
  97. Polesel DN, Hirotsu C, Nozoe KT, Boin AC, Bittencourt L, et al. (2015) Waist circumference and postmenopause stages as the main associated factors for sleep apnea in women: a cross-sectional population-based study.Menopause 22: 835-844.
  98. Tasali E, Van Cauter E, Ehrmann DA (2008) Polycystic Ovary Syndrome and Obstructive Sleep Apnea.Sleep Med Clin 3: 37-46.
  99. Tock L, Carneiro G, Togeiro SM, Hachul H, Pereira AZ, et al. (2014) Obstructive sleep apnea predisposes to nonalcoholic Fatty liver disease in patients with polycystic ovary syndrome.EndocrPract 20: 244-251.
  100. Nitsche K, Ehrmann DA (2010) Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome.Best Pract Res ClinEndocrinolMetab 24: 717-730.
  101. Mokhlesi B, Scoccia B, Mazzone T, Sam S (2012) Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women.FertilSteril 97: 786-791.
  102. Tasali E, Van Cauter E, Hoffman L, Ehrmann DA (2008) Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome.J ClinEndocrinolMetab 93: 3878-3884.
  103. Koseoglu S, Ikinciogullari A, Cetin MA, Uysal GS, Kum RO, et al. (2013) The clinical efficiency of positive airway pressure treatment.ScientificWorldJournal 2013: 245476.
  104. Budweiser S, Luigart R, Jörres RA, Kollert F, Kleemann Y, et al. (2013) Long-term changes of sexual function in men with obstructive sleep apnea after initiation of continuous positive airway pressure.J Sex Med 10: 524-531.
  105. Ju G (2012) Modest changes in cerebral glucose metabolism in patients with sleep apnea syndrome after continuous positive airway pressure treatment. Respiration 84: 212-218.
  106. Daskalopoulou EG, Liavvas C, Nakas CT, Vlachogiannis EG, Bouros D, et al. (2011) Obstructive sleep apnoea syndrome promotes reversal albuminuria during sleep.Sleep Breath 15: 589-597.
  107. Wolkove N, Elkholy O, Baltzan M, Palayew M (2007) Sleep and aging: 2. Management of sleep disorders in older people.CMAJ 176: 1449-1454.
  108. Celec P, Mucska I, Ostatníková D, Hodosy J (2014) Testosterone and estradiol are not affected in male and female patients with obstructive sleep apnea treated with continuous positive airway pressure.J Endocrinol Invest 37: 9-12.
  109. Hastings PC, Vazir A, Meadows GE, Dayer M, Poole-Wilson PA, et al. (2010) Adaptive servo-ventilation in heart failure patients with sleep apnea: a real world study.Int J Cardiol 139: 17-24.
  110. Shantha GP, Pancholy SB (2015) Effect of renal sympathetic denervation on apnea-hypopnea index in patients with obstructive sleep apnea: a systematic review and meta-analysis. Sleep Breath 19: 29-34.
  111. Å ujanská A, Ä?urdìk P, Rabasco J, Vitelli O, Pietropaoli N, et al. (2014) SURGICAL AND NON-SURGICAL THERAPY OF OBSTRUCTIVE SLEEP APNEA SYNDROME IN CHILDREN.ActaMedica (Hradec Kralove) 57: 135-141.
  112. Choi JH (2015) Sleep quality change after upper airway surgery in obstructive sleep apnea: Electrocardiogram-based cardiopulmonary coupling analysis. Laryngoscope.
  113. Lu CH (2015) Increased circulating endothelial progenitor cells and antioxidant capacity in obstructive sleep apnea after surgical treatment. ClinChimActa.
  114. Günbey E, Karabulut I, Karabulut H, Zaim M (2015) Impact of Multilevel Surgical Treatment on Mean Platelet Volume in Patients With Obstructive Sleep Apnea Syndrome.J CraniofacSurg 26: 1287-1289.
  115. Com G, Carroll JL, Tang X, Melguizo MS, Bower C, et al. (2015) Characteristics and surgical and clinical outcomes of severely obese children with obstructive sleep apnea. J Clin Sleep Med 11: 467-474.